<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link brand__border-color" href="/government/organisations/nhs-commissioning-board">
      <span class="gem-c-organisation-logo__name">NHS England</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    CF laboratory guide pathways: text versions
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 31 May 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#figure-1-cystic-fibrosis-cf-screening-algorithm" data-track-options="{&quot;dimension29&quot;:&quot;Figure 1: cystic fibrosis (CF) screening algorithm&quot;}" href="#figure-1-cystic-fibrosis-cf-screening-algorithm">Figure 1: cystic fibrosis (CF) screening algorithm</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#figure-2-handling-of-irt-results-from-the-first-screening-specimen" data-track-options="{&quot;dimension29&quot;:&quot;Figure 2: Handling of IRT results from the first screening specimen&quot;}" href="#figure-2-handling-of-irt-results-from-the-first-screening-specimen">Figure 2: Handling of IRT results from the first screening specimen</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#figure-3-handling-of-late-first-irt-samples" data-track-options="{&quot;dimension29&quot;:&quot;Figure 3: handling of late first IRT samples&quot;}" href="#figure-3-handling-of-late-first-irt-samples">Figure 3: handling of late first IRT samples</a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/cystic-fibrosis-screening-laboratory-handbook/cf-laboratory-guide-pathways-text-versions
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<p>The information below provides a text description of each of the pathways (figures 1, 2 and 3) shown in the <a class="govuk-link" href="https://www.gov.uk/government/publications/cystic-fibrosis-screening-laboratory-handbook">cystic fibrosis screening laboratory handbook</a>.</p>

<h2>Figure 1: cystic fibrosis (<abbr title="cystic fibrosis">CF</abbr>) screening algorithm</h2>

<p>Blood spot sample immunoreactive trypsin (<abbr title="immunoreactive trypsinogen">IRT</abbr>) assay. The routine newborn blood spot (<abbr title="newborn blood spot">NBS</abbr>) sample should be taken on day 5 (day if birth is day 0). Assay in singleton.</p>

<h3>
<span class="number">1. </span> Is the <abbr title="immunoreactive trypsinogen">IRT</abbr> above or below the cut-off A?</h3>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to cut-off A: re-assay in duplicate. Go to question 2.</p>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> below cut-off A: <abbr title="cystic fibrosis">CF</abbr> not suspected. End of pathway.</p>

<h3>
<span class="number">2. </span> Is the <abbr title="immunoreactive trypsinogen">IRT</abbr> above or below cut-off B?</h3>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to cut-off B: carry out <abbr title="deoxyribonucleic acid">DNA</abbr> analysis (4 panel) Go to question 3.</p>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> below cut-off B: <abbr title="cystic fibrosis">CF</abbr> not suspected. End of pathway.</p>

<h3>
<span class="number">3. </span> Were any <abbr title="cystic fibrosis transmembrane conductance regulator">CFTR</abbr> variants detected?</h3>

<p>Yes: Go to question 6.</p>

<p>No: go to question 4.</p>

<h3>
<span class="number">4. </span> Is the <abbr title="immunoreactive trypsinogen">IRT</abbr> above or below 120µg/L?</h3>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to 120µg/L: <abbr title="immunoreactive trypsinogen">IRT</abbr> on repeat blood spot sample (assay in duplicate). Go to question 5.</p>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> below 120 µg/L: <abbr title="cystic fibrosis">CF</abbr> not suspected. End of pathway.</p>

<h3>
<span class="number">5. </span> Is the <abbr title="immunoreactive trypsinogen">IRT</abbr> above or below cut-off A?</h3>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to cut-off A: <abbr title="cystic fibrosis">CF</abbr> suspected. End of pathway.</p>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> below cut-off A: <abbr title="cystic fibrosis">CF</abbr> not suspected. End of pathway.</p>

<h3>
<span class="number">6. </span> How many <abbr title="cystic fibrosis transmembrane conductance regulator">CFTR</abbr> variants detected?</h3>

<p>One: Carry out <abbr title="deoxyribonucleic acid">DNA</abbr> analysis (50-100 panel). Go to question 7.</p>

<p>Two: <abbr title="cystic fibrosis">CF</abbr> suspected. End of pathway.</p>

<h3>
<span class="number">7. </span> How many <abbr title="cystic fibrosis transmembrane conductance regulator">CFTR</abbr> variants detected?</h3>

<p>One: <abbr title="immunoreactive trypsinogen">IRT</abbr> on repeat blood spot sample (assay in duplicate). Go to question 8.</p>

<p>Two: <abbr title="cystic fibrosis">CF</abbr> suspected. End of pathway.</p>

<h3>
<span class="number">8. </span> Is the <abbr title="immunoreactive trypsinogen">IRT</abbr> above or below cut-off A?</h3>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to cut-off A: <abbr title="cystic fibrosis">CF</abbr> suspected. End of pathway.</p>

<p><abbr title="immunoreactive trypsinogen">IRT</abbr> below cut-off A: Probable carrier. End of pathway.</p>

<p><br>
<strong>End of text description for figure 1 pathway</strong>.</p>

<h2>Figure 2: Handling of <abbr title="immunoreactive trypsinogen">IRT</abbr> results from the first screening specimen</h2>

<p>The average of 3 <abbr title="immunoreactive trypsinogen">IRT</abbr> results is above or equal to cut-off B. (Note that cut-off A should be used if the sample was collected on or after day 21 (day of birth counted as day 0).</p>

<h3>
<span class="number">1. </span> Are the results discrepant?</h3>

<p>Yes: Go to question 2.</p>

<p>No: Accept the average result. End of pathway.</p>

<h3>
<span class="number">2. </span> Are 2 results above or equal to cut-off B? (Note that cut-off A should be used if the sample was collected on or after day 21 (day of birth counted as day 0).</h3>

<p>Yes: Go to question 3.</p>

<p>No: Report <abbr title="cystic fibrosis">CF</abbr> not suspected. End of pathway.</p>

<h3>
<span class="number">3. </span> Is the average <abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to 120µg/L?</h3>

<p>Yes: Request a repeat sample. If the repeat sample cannot be taken before day 21, immediate referral is indicated. End of pathway.</p>

<p>No: Send for genetic analysis. End of pathway.</p>

<p><br>
<strong>End of text description for figure 2 pathway</strong>.</p>

<h2>Figure 3: handling of late first <abbr title="immunoreactive trypsinogen">IRT</abbr> samples</h2>

<p>Late first <abbr title="immunoreactive trypsinogen">IRT</abbr> sample. Establish the age of the baby (day of birth is counted as day 0).</p>

<h3>
<span class="number">1.Is </span> the baby aged day 6 to 20 inclusive?</h3>

<p>Yes: Follow the standard <abbr title="cystic fibrosis">CF</abbr> screening protocol. End of pathway.</p>

<p>No: Go to question 2.</p>

<h3>
<span class="number">2. </span> Is the baby aged day 21 to 56 inclusive?</h3>

<p>Yes: Assess <abbr title="immunoreactive trypsinogen">IRT</abbr> against cut-off A and follow the standard <abbr title="cystic fibrosis">CF</abbr> screening protocol. End of pathway.</p>

<p>No: Go to question 3.</p>

<h3>
<span class="number">3. </span> Is the baby aged over 56 days (8 weeks) and the sample has been taken but not yet analysed?</h3>

<p>Yes: Report as not screened for <abbr title="cystic fibrosis">CF</abbr>. Inform the GP and child health records department (<abbr title="child health records department">CHRD</abbr>). Only refer if the baby has clinical signs of <abbr title="cystic fibrosis">CF</abbr>. End of pathway.</p>

<p>No: Go to question 4.</p>

<h3>
<span class="number">4. </span> Is the baby aged over 56 days (8 weeks) and the sample has been taken and unavoidably analysed, with an <abbr title="immunoreactive trypsinogen">IRT</abbr> above or equal to cut-off A?</h3>

<p>Yes: Refer as <abbr title="cystic fibrosis">CF</abbr> suspected and arrange genetic analysis. End of pathway.</p>

<p>No: Report as not screened for <abbr title="cystic fibrosis">CF</abbr>. Inform the GP and child health records department (<abbr title="child health records department">CHRD</abbr>). Only refer if the baby has clinical signs of <abbr title="cystic fibrosis">CF</abbr>. End of pathway.</p>

<p><br>
<strong>End of text description for figure 3 pathway</strong>.</p>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>